ANEURYSM@RISK: Automatic Intracranial Aneurysm Quantification and Feature Learning Modelling to Optimize Intracranial Aneurysm Rupture Prediction
NCT ID: NCT07111975
Last Updated: 2025-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
3800 participants
OBSERVATIONAL
2025-01-01
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study utilizes retrospective imaging data from multiple European centers, including UMC Utrecht, AP-HP Paris, and University Medical Center Hamburg-Eppendorf (UKE). A clinical vignette study will evaluate the model's clinical utility and user experience among interventional radiologists.
This study is exempt from medical ethics review (non-WMO in the Netherlands), as it involves only existing, anonymized data and imposes no additional burden on patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AI for Detection of Brain Aneurysm: Low-cost Opportunistic Screening
NCT07123818
Brain Imaging After Non-traumatic Intracranial Hemorrhage (SAVEBRAINPWI)
NCT05276934
Investigation of Hemodynamics and Radiomics Based on High Resolution Magnetic Resonance Imaging for Predicting the Outcomes of Intracranial Dissecting Aneurysm
NCT07335029
AI Models for Cerebral Aneurysms Segmentation, Detection and Stability Prediction
NCT06766422
A Study on a Multidimensional Prediction Model for Rupture Risk of Unruptured Intracranial Aneurysms
NCT03133624
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Retrospective MR angiography (MRA) data will be collected from three clinical sites: UMC Utrecht (The Netherlands), AP-HP Paris (France), and University Medical Center Hamburg-Eppendorf (Germany). The study workflow includes:
* Development of AI algorithms for 3D shape feature extraction after automated aneurysm segmentation
* Training of predictive models for aneurysm growth and rupture based on morphological and clinical parameters
* Validation of model performance using a longitudinal dataset of \~1,000 patients (target C-statistic ≥ 0.80)
* A clinical vignette study in real-life settings to evaluate usability, decision-making impact, and inter-clinician variability
Key Performance Indicators (KPIs):
* Discriminative performance for aneurysm instability prediction; C-statistic ≥ 0.80
* Sensitivity ≥ 80% and specificity ≥ 50% (based on optimal cut-off values)
* ≥ 25% reduction in time to clinical decision-making
* ≥ 80% adherence to AI-generated suggestions by interventional radiologists
* ≥ 20% improvement in user experience using 3D visualization compared to 2D displays (survey-based)
* ≥ 50% reduction in inter- and intra-observer variability in aneurysm assessment
Ethical Considerations:
This is a non-interventional, retrospective study using previously acquired and anonymized imaging data. No additional procedures or data collection will be performed. The study poses no added burden or risk to patients. According to Dutch regulations, it is not subject to the Medical Research Involving Human Subjects Act (non-WMO).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stable Intracranial Aneurysm Group
Participants with unruptured intracranial aneurysms (UIAs) that remained stable over time, showing no morphological growth or rupture during follow-up. Data are sourced from UMC Utrecht, UKE Hamburg, and AP-HP Paris.
No interventions assigned to this group
Unstable Intracranial Aneurysm Group
Participants with intracranial aneurysms (IAs) that demonstrated instability over time, defined as morphological growth and/or rupture during follow-up. Data are sourced from UMC Utrecht, UKE Hamburg, and AP-HP Paris.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of at least one intracranial aneurysm (IA)
* Availability of follow-up imaging or clinical records indicating stability, growth, or rupture
Exclusion Criteria
* Lack of follow-up data
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AP-HP (Assistance Publique - Hôpitaux de Paris), FRANCE : Hôpital Pitié Salpêtrière, Hôpital Bichat
UNKNOWN
University Medical Center Hamburg-Eppendorf (UKE)
UNKNOWN
Philips Medical Systems
INDUSTRY
UMC Utrecht
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Phebe J Groenheide, MSc
PhD Candidate, Department of Radiology/Neurology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Center (UMC) Utrecht
Utrecht, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
SHERPA: Smart Human-centred Effortless support for Professional clinical Applications
SHERPA: Smart Human-centred Effortless support for Professional clinical Applications
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23U-0036_AWARE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.